Eye Blink Rate as a biological marker of Mild Cognitive Impairment

International Journal of Psychophysiology

Volumn 93, Issue 1, 2014, Pages 12-16

  Ladas, Aristea ^a   Frantzidis, Christos ^b   Bamidis, Panagiotis ^b   Vivas, Ana B ^a  

^a UNIVERSITY OF SHEFFIELD   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Biological marker; Dopamine; Eye Blink Rate; MCI

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE;

ADULT; ADULT DISEASE; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ELECTROOCULOGRAPHY; EXECUTIVE FUNCTION; EYE BLINK RATE; EYELID REFLEX; FEMALE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NERVOUS SYSTEM PARAMETERS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGIC TEST; SHORT TERM MEMORY; WORKING MEMORY; ATTENTION; BLINKING; MEMORY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATTENTION; BIOLOGICAL MARKERS; BLINKING; DOPAMINE; ELECTROOCULOGRAPHY; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 84904738203     PISSN: 01678760     EISSN: 18727697     Source Type: Journal    
DOI: 10.1016/j.ijpsycho.2013.07.010     Document Type: Article

References (72)

1. Ahmed S., Arnold R., Thompson S.A., Graham K.S., Hodges J.R. Names of objects, faces and buildings in mild cognitive impairment. Cortex 2008, 44:746-752.
2. Ahmed S., Mitchell J., Arnold R., Nestor P.J., Hodges J.R. Predicting rapid clinical progression in amnestic mild cognitive impairment. Dementia and Geriatric Cognitive Disorders 2008, 25:170-177.
3. Aggarwal A., Kean E. Comparison of the folstein mini mental state examination (mmse) to the montreal cognitive assessment (MoCA) as a cognitive screening tool in an inpatient rehabilitation setting. Neuroscience and Medicine 2010, 1:39-42.
4. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011, 7:270-279.
5. Alzheimer's Disease International The Global Economic Impact of Dementia 2010, Author, UK, (Retrieved from http://www.alz.co.uk/research/files/WorldAlzheimerReport2010.pdf).
6. Arnáiz E., Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurologica Scandinavica. Supplementum 2003, 179:34-41.
7. Bäckman L., Andersson J.L.R., Nyberg L., Winblad B., Nordberg A., Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 1999, 52:1861-1870.
8. Bäckman L., Ginovart N., Dixon R.A., Robins Wahlin T.B., Wahlin A., Halldin C., Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. American Journal of Psychiatry 2000, 157:635-637.
9. Bäckman L., Nyberg L., Lindenberger U., Lib S.C., Farde L. The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neuroscience and Biobehavioral Reviews 2006, 30:791-807.
10. Bamidis P.D., Konstantinidis E.I., Billis A., Frantzidis C., Tsolaki M., Hlauschek W., et al. A Web services-based exergaming platform for senior citizens: the Long Lasting Memories project approach to e-health care. Conference proceedings: . . . Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2011, 2011:2505-2509.
11. Bentivoglio A.R., Bressman S.B., Cassetta E., Carretta D., Tonali P., Albanese A. Analysis of blink rate patterns in normal subjects. Movement Disorders 1997, 12:1028-1034.
12. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiology of Aging 1997, 18:351-357.
13. Braak H., Rüb U., Jansen Steur E.N., Del Tredici K., de Vos R.A. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005, 64:1404-1410.
14. Brayne C. The mini-mental state examination, will we be using it in 2001?. International Journal of Geriatric Psychiatry 1998, 13:285-294.
15. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimer's & Dementia 2007, 3:186-191.
16. Brooks J.M., Sarter M., Bruno J.P. D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex. Neuropharmacology 2007, 53:455-463.
17. Burianova H., McIntosh A.R., Grady C.L. A common functional brain network for autobiographical, episodic, and semantic memory retrieval. NeuroImage 2010, 49:865-874.
18. Burns A., Zaudig M. Mild cognitive impairment in older people. Lancet 2002, 360:1963-1965.
19. Chen W.H., Chiang T.J., Hsu M.C., Liu J.S. The validity of eye blink rate in Chinese adults for the diagnosis of Parkinson's disease. Clinical Neurology and Neurosurgery 2003, 105:90-92.
20. Clément F., Belleville S. Compensation and disease severity on the memory-related activations in mild cognitive impairment. Biological Psychiatry 2010, 68:894-902.
21. Colzato L.S., van den Wildenberg W.P.M., van Wouwe N.C., Pannebakker M.M., Hommel B. Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Experimental Brain Research 2009, 196:467-474.
22. Colzato L.S., van den Wildenberg W.P.M., Hommel B. Reduced spontaneous eye blink rates in recreational cocaine users: evidence for dopaminergic hypoactivity. Plos One 2008, 3:1-4.
23. Coward L.A. The hippocampal system as the cortical resource manager: a model connecting psychology, anatomy and physiology. Advances in Experimental Medicine and Biology 2010, 657:315-364.
24. Delacourt A., David J.P., Sergeant N., Buee L., Wattez A., Vermersch P., et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999, 52:1158-1165.
25. De Padova V., Barbato G., Conte F., Ficca G. Diurnal variation of spontaneous eye blink rate in the elderly and its relationships with sleepiness and arousal. Neuroscience Letters 2009, 463:40-43.
26. Dudas R.B., Clague F., Thompson S.A., Graham K.S., Hodges J.R. Episodic and semantic memory in mild cognitive impairment. Neuropsychologia 2005, 43:1266-1276.
27. Elsworth J.D., Lawrence M.S., Roth R.H., Taylor J.R., Mailman R.B., Nichols D.E., Lewis M.H., Redmond D.E. D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. Journal of Pharmacology and Experimental Therapeutics 1991, 259:595-600.
28. Fayed N., Da'vila J., Oliveros A.Jr, Medrano J., Castillo J. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment. Neurology Research 2010, 32:157-165.
29. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
30. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state", a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
31. Hosp J.A., Pekanovic A., Rioult-Pedotti M.S., Luft A.R. Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. The Journal of Neuroscience 2011, 16:2481-2487.
32. Kalpouzos G., Chetelat G., Landeau B., Clochon P., Viader F., Eustache F., et al. Structural and metabolic correlates of episodic memory in relation to the depth of encoding in normal aging. Journal of Cognitive Neuroscience 2009, 21:372-389.
33. Karson C.N. Spontaneous eye-blink rates and dopaminergic system. Brain 1983, 53:106-643.
34. Karson C.N., Freed W.J., Kleinman J.E., Bigelow L.B., Wyatt B.J. Neuroleptics decrease blink rates in schizophrenic subjects. Biological Psychiatry 1981, 16:679-682.
35. Karson C.N., LeWitt P.A., Calne D.B., Wyatt R.J. Blink rates in parkinsonism. Annals of Neurology 1982, 12:580-583.
36. Kemppainen N., et al. Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease. European Journal of Neuroscience 2003, 18:149-154.
37. Lawrence M.S., Redmond D.E. MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacology Biochemistry and Behavior 1991, 38:869-874.
38. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist 1969, 9:179-186.
39. Leyhe T., Müller S., Milian M., Eschweiler G.W., Saur R. Impairment of episodic and semantic autobiographical memory in patients with mild cognitive impairment and early Alzheimer's disease. Neuropsychologia 2009, 47:2464-2469.
40. Luciana M., Collins P.F. Dopaminergic modulation of memory for spatial but not objects cues in normal humans. Journal of Cognitive Neuroscience 1997, 9:330-347.
41. Luciana M., Collins P.F., Depue R.A. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex 1998, 8:218-226.
42. Mackert A., Flechntner K.M., Woyth C., Frick K. Increased blink rates in schizophrenics. Influences of neuroleptics and psychopathology. Schizophrenia Research 1991, 4:41-47.
43. Martorana A., Esposito Z., Koch G. Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?. CNS Neuroscience and Therapeutics 2010, 16:235-245.
44. Martorana A., Mori F., Esposito Z., et al. Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacology 2009, 34:2323-2328.
45. Martorana A., Stefani A., Palmieri M.G., Esposito Z., Bernardi G., Sancesario G., Pierantozzi M. l-dopa modulates motor cortex excitability in Alzheimer's disease patients. Journal of Neural Transmission 2008, 115:1313-1319.
46. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., et al. Mild cognitive impairment represents early-stage Alzheimer disease. Archives of Neurology 2001, 58:397-405.
47. Nagaraja D., Sivaramakrishnan J. Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. The American Journal of Psychiatry 2001, 158:1517-1519.
48. Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 2005, 53:695-699.
49. Nazem S., Siderowf A.D., Duda J.E., Have T.T., Colcher A., Horn S.S., et al. Montreal Cognitive Assessment performance in patients with Parkinson's disease with "normal" global cognition according to Mini-Mental State Examination score. Journal of the American Geriatrics Society 2009, 57:304-308.
50. Pennisi G., Ferri R., Lanza G., Cantone M., Pennisi M., Puglisi V., et al. Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability. Journal of Neural Transmission 2011, 118:587-598.
51. Petersen R.C., Morris J.C. Mild cognitive impairment as a clinical entity and treatment target. Archives of Neurology 2005, 62:1160-1163.
52. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 1133-1142.
53. Van der Post J., De Waal P.P., De Kam M.L., Cohen A.F., van Gerven J.M.A. No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity. Journal of Psychopharmacology 2004, 18(1):109-114.
54. Reitan R.M., Wolfson D. Category test and trail making test as measures of frontal lobe functions. The Clinical Neuropsychologist 1995, 9:50-56.
55. Rinne J.O., Någren K. Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease. Journal of Alzheimer's Disease 2010, 19:291-300.
56. Schultz-Larsen K., Lomholt R.K., Kreiner S. Mini-Mental Status Examination: a short form of MMSE was as accurate as the original MMSE in predicting dementia. Journal of Clinical Epidemiology 2007, 60:260-267.
57. Schuck S., Bentue-Ferrer D., Kleinermans D., Reymann J.M., Polard E., Gandon J.M., et al. Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers. Fundamental & Clinical Pharmacology 2002, 16:57-65.
58. Sheikh J.I., Yesavage J.A. Geriatric depression scale (GDS): recent evidence and development of a shorter version. The Journal of Aging and Mental Health 1986, 5:165-173.
59. Shukla D. Blink rate as clinical indicator. Neurology 1985, 35:286.
60. Sweet L., Van Adel M., Metcalf V., Wright L., Harley A., Leiva R., Taler V. The Montreal Cognitive Assessment (MoCA) in geriatric rehabilitation: psychometric properties and association with rehabilitation outcomes. International Psychogeriatrics 2011, 23:1582-1591.
61. Sun W.S., Baker R.S., Chuke J.C., Rouholiman B.R., Hasan S.D.A., Gaza W., et al. Age-related changes in human blinks. Passive and active changes in eyelid kinematics. Investigative Ophthalmology & Visual Science 1997, 38:92-99.
62. Taylor J.R., Elsworth J.D., Lawrence M.S., Sladek J.R., Roth R.H., Redmond D.E. Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Experimental Neurology 1999, 158:214-220.
63. Tombaugh T.N., McIntyre N.J. The mini-mental state examination: a comprehensive review. Journal of the American Geriatrics Society 1992, 40:922-935.
64. Volkow N.D., Gur R.C., Wang G.-J., Fowler J.S., Moberg P.J., Ding Y.-S., et al. The American Journal of Psychiatry 1998, 155:344-349.
65. Wagner A.D. Early detection of Alzheimer's disease: an fMRI marker for people at risk?. Nature Neuroscience 2000, 3:973-974.
66. Wechsler D. WAIS-R manual 1981, Psychological Corporation, San Antonio, TX.
67. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 2004, 256:240-246.
68. Woodard J.L., Seidenberg M., Nielson K.A., Antuono P., Guidotti L., Durgerian S., et al. Semantic memory activation in amnestic mild cognitive impairment. Brain 2009, 132:2068-2078.
69. World Health Organization World Health Report 2003-Shaping the Future 2003, WHO, Geneva.
70. Wind A.W., Schellevis F.G., Van Staveren G., et al. Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice. International Journal of Geriatric Psychiatry 1997, 12:101-108.
71. Yochim B.P., Feliciano L., Cornwell R.E., Davis H.P. Predictive validity of the SLUMS and MMSE among older adults. Presentation at the American Psychological Association Annual Convention 2008.
72. Zahrt J., Taylor J.R., Mathew R.G., Arnsten A.F.T. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. The Journal of Neuroscience 1997, 17:8528-8535.